Numerous clinical trials spanning Early Phase I through Phase IV evaluate vincristine sulfate in pediatric oncologic conditions and hematologic malignancies, including B-cell acute lymphoblastic leukemia, non-Hodgkin lymphoma, peripheral T-cell lymphoma, and advanced solid tumors. Driven largely by academic and cooperative sponsors—such as the National Cancer Institute, Children's Oncology Group, and St. Jude Children's Research Hospital—these studies investigate pharmacokinetic profiles and multi-agent therapeutic strategies. Across recruiting, active not recruiting, completed, and withdrawn protocols, multiple clinical trials reflect the compound's broad integration into cancer treatment regimens.
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT07220187 | NOT_YET_RECRUITING | Richter Syndrome; Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma; Transformed Small Lymphocytic Lymphoma to Diffuse Large B-Cell Lymphoma |
SWOG Cancer Research Network |
2026-08-31 | PHASE3 |
| NCT07072585 | NOT_YET_RECRUITING | Stage II T Lymphoblastic Leukemia/Lymphoma; Stage III T Lymphoblastic Leukemia/Lymphoma; Stage IV T Lymphoblastic Leukemia/Lymphoma; T Acute Lymphoblastic Leukemia; T Lymphoblastic Lymphoma |
Children's Oncology Group |
2026-08-28 | PHASE2; PHASE3 |
| NCT04681417 | RECRUITING | Retinoblastoma |
Institut Curie |
2021-03-25 | PHASE2; PHASE3 |
| NCT07724457 | NOT_YET_RECRUITING | Recurrent Burkitt Lymphoma; Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 Rearrangements; Refractory Burkitt Lymphoma; Refractory High Grade B-Cell Lymphoma With MYC and BCL2 Rearrangements |
National Cancer Institute (NCI) |
2026-10-30 | PHASE2; PHASE3 |
| NCT07387926 | RECRUITING | Acute Lymphoblastic Leukemia; Leukemia, Lymphoblastic, Acute, Philadelphia-Positive; Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia |
Novartis Pharmaceuticals |
2026-07-05 | PHASE1; PHASE2 |
| NCT04307576 | RECRUITING | Leukemia, Acute Lymphoblastic |
Mats Heyman |
2020-07-13 | PHASE3 |
| NCT06947967 | RECRUITING | Lymphoma, T-Cell, Peripheral |
Chipscreen Biosciences, Ltd. |
2025-08-12 | PHASE3 |
| NCT07321912 | RECRUITING | Osteosarcoma; Ewing Sarcoma |
Milton S. Hershey Medical Center |
2026-06-05 | PHASE2 |
| NCT07662928 | NOT_YET_RECRUITING | Adult Burkitt Lymphoma |
AIDS Malignancy Consortium |
2026-09-17 | PHASE2 |
| NCT05675410 | RECRUITING | Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 |
National Cancer Institute (NCI) |
2023-05-11 | PHASE3 |
| NCT05605899 | ACTIVE_NOT_RECRUITING | High-risk Large B-cell Lymphoma (LBCL) |
Kite, A Gilead Company |
2023-02-10 | PHASE3 |
| NCT06401330 | RECRUITING | Stage I Mixed Cell Type Kidney Wilms Tumor; Stage II Mixed Cell Type Kidney Wilms Tumor; Stage III Mixed Cell Type Kidney Wilms Tumor; Stage IV Mixed Cell Type Kidney Wilms Tumor |
Children's Oncology Group |
2025-04-15 | PHASE3 |
| NCT07712588 | NOT_YET_RECRUITING | Diffuse Large B-Cell Lymphoma (DLBCL) |
Dizal Pharmaceuticals |
2026-09 | PHASE2; PHASE3 |
| NCT07654426 | RECRUITING | Diffuse Large B-cell Lymphoma (DLBCL); Cardiotoxicity; Lymphoma |
Beth Israel Deaconess Medical Center |
2026-08-31 | PHASE2 |
| NCT04166409 | RECRUITING | Low Grade Astrocytoma; Low Grade Glioma; Metastatic Low Grade Astrocytoma; Metastatic Low Grade Glioma; WHO Grade 1 Glioma; WHO Grade 2 Glioma |
National Cancer Institute (NCI) |
2020-01-31 | PHASE3 |
| NCT07431060 | RECRUITING | Langerhans Cell Histiocytosis (LCH) |
West China Second University Hospital |
2026-02-13 | |
| NCT07227584 | RECRUITING | Acute Lymphoblastic Leukemia; Philadelphia Chromosome-Negative Lymphoblastic Leukemia; Acute Lymphoblastic Leukemia (ALL); Leukemia |
Dana-Farber Cancer Institute |
2026-04-03 | PHASE2 |
| NCT07719855 | NOT_YET_RECRUITING | Follicular Lymphoma ( FL) |
Ruijin Hospital |
2026-07 | PHASE3 |
| NCT06721689 | RECRUITING | Refractory Solid Tumors; Relapsed Solid Tumors; Relapsed Neuroblastoma; Refractory Neuroblastoma; Relapsed Rhabdomyosarcoma; Refractory Rhabdomyosarcoma |
Theodore Laetsch |
2025-03-23 | PHASE1; PHASE2 |
| NCT06172296 | RECRUITING | Ganglioneuroblastoma, Nodular; Neuroblastoma |
National Cancer Institute (NCI) |
2024-04-19 | PHASE3 |
| NCT07493148 | RECRUITING | Diffuse Large B-Cell Lymphoma (DLBCL) |
Ou Bai, MD/PHD |
2026-04-30 | PHASE2 |
| NCT00887146 | ACTIVE_NOT_RECRUITING | Brain and Central Nervous System Tumors |
Alliance for Clinical Trials in Oncology |
2009-09 | PHASE3 |
| NCT06528496 | RECRUITING | High-risk Neuroblastoma; Neuroblastoma; Childhood Neuroblastoma |
Memorial Sloan Kettering Cancer Center |
2024-07-22 | PHASE2 |
| NCT06564038 | RECRUITING | Chronic Lymphocytic Leukaemia; Small Lymphocytic Lymphoma; Mantle-cell Lymphoma; Large B-cell Lymphoma; B-cell Non-Hodgkin Lymphoma |
AstraZeneca |
2025-01-30 | PHASE1; PHASE2 |
| NCT05848765 | RECRUITING | Relapsed Follicular Lymphoma; Refractory Follicular Lymphoma |
University of Birmingham |
2023-09-04 | PHASE2 |
| NCT06188676 | RECRUITING | Primary Mediastinal Lymphoma |
National Research Center for Hematology, Russia |
2022-04-01 | PHASE3 |
| NCT06647953 | RECRUITING | Pleuropulmonary Blastoma |
Children's Oncology Group |
2025-03-21 | PHASE3 |
| NCT06918431 | RECRUITING | B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative; Lymphoblastic Lymphoma |
City of Hope Medical Center |
2025-10-10 | PHASE2 |
| NCT07301138 | NOT_YET_RECRUITING | Acute Lymphoblastic Leukemia |
Ruijin Hospital |
2025-12-15 | PHASE2 |
| NCT04199026 | RECRUITING | Metastatic Sarcoma; Recurrent Sarcoma; Resectable Sarcoma |
M.D. Anderson Cancer Center |
2025-02-25 | |
| NCT06220032 | RECRUITING | DLBCL - Diffuse Large B Cell Lymphoma |
Stichting Hemato-Oncologie voor Volwassenen Nederland |
2024-08-15 | PHASE3 |
| NCT04884035 | ACTIVE_NOT_RECRUITING | Lymphoma, B-Cell |
Celgene |
2021-09-15 | PHASE1 |
| NCT07258680 | ENROLLING_BY_INVITATION | Peripheral T-cell Lymphoma |
N.N. Petrov National Medical Research Center of Oncology |
2013-10 | PHASE3 |
| NCT06709495 | RECRUITING | Sarcoma; Sarcoma, Ewing; Desmoplastic Small Round Cell Tumor; Refractory Sarcoma; Osteosarcoma; Rhabdomyosarcoma |
David S Shulman, MD |
2025-01-27 | PHASE1; PHASE2 |
| NCT01878617 | ACTIVE_NOT_RECRUITING | Medulloblastoma |
St. Jude Children's Research Hospital |
2013-06-23 | PHASE2 |
| NCT07224100 | RECRUITING | B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1; B Lymphoblastic Leukemia/Lymphoma With t(9;22)(q34.1;q11.2); BCR-ABL1; Lymphoblastic Lymphoma |
University of Washington |
2026-03-30 | PHASE2 |
| NCT05888493 | ACTIVE_NOT_RECRUITING | Follicular Lymphoma (FL) |
Novartis Pharmaceuticals |
2023-10-02 | PHASE3 |
| NCT03643276 | RECRUITING | Acute Lymphoblastic Leukemia, Pediatric |
Martin Schrappe |
2018-07-15 | PHASE3 |
| NCT04546399 | RECRUITING | Down Syndrome; Recurrent B Acute Lymphoblastic Leukemia |
National Cancer Institute (NCI) |
2020-12-17 | PHASE2 |
| NCT05389423 | RECRUITING | Diffuse Large Cell Lymphoma; Non-Hodgkin Lymphoma; Burkitt Lymphoma; Plasmablastic Lymphoma; B-Cell Neoplasm |
National Cancer Institute (NCI) |
2023-06-27 | PHASE1 |
| NCT07643103 | NOT_YET_RECRUITING | Ph- Acute Lymphoblastic Leukemia (Ph-ALL) |
Institute of Hematology & Blood Diseases Hospital, China |
2026-06-12 | PHASE2 |
| NCT03984448 | ACTIVE_NOT_RECRUITING | Diffuse Large B-Cell Lymphoma; Diffuse Large B-Cell Lymphoma, Not Otherwise Specified; Double-Expressor Lymphoma; EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified; High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; High Grade B-Cell Lymphoma, Not Otherwise Specified; Neoplastic Cells With Double Expression of MYC and BCL2 Proteins Present; Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma |
National Cancer Institute (NCI) |
2019-10-22 | PHASE2; PHASE3 |
| NCT05504291 | RECRUITING | Bilateral Retinoblastoma; Childhood Intraocular Retinoblastoma; Group D Retinoblastoma; Stage I Retinoblastoma; Unilateral Retinoblastoma |
Children's Oncology Group |
2022-11-04 | PHASE2 |
| NCT02724579 | ACTIVE_NOT_RECRUITING | Medulloblastoma |
Children's Oncology Group |
2017-11-17 | PHASE2 |
| NCT06091254 | RECRUITING | Follicular Lymphoma (FL) |
Regeneron Pharmaceuticals |
2023-12-12 | PHASE3 |
| NCT07676175 | NOT_YET_RECRUITING | Previously Untreated Peripheral T-Cell Lymphoma |
BeBetter Med Inc |
2026-07-01 | PHASE2 |
| NCT03871257 | ACTIVE_NOT_RECRUITING | Low Grade Glioma; Neurofibromatosis Type 1; Visual Pathway Glioma |
National Cancer Institute (NCI) |
2020-01-15 | PHASE3 |
| NCT07535762 | NOT_YET_RECRUITING | Peripheral T-Cell Lymphoma (PTCL NOS); Nodal T-follicular Helper Cell Lymphoma; Anaplastic Large Cell Lymphoma (ALCL) (ALK-1 Negative) |
Shanghai Jiao Tong University School of Medicine |
2026-03-30 | PHASE2 |
| NCT01371630 | RECRUITING | B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1; B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative; Burkitt-Like Lymphoma With 11q Aberration; High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements; High Grade B-Cell Lymphoma, Not Otherwise Specified; Recurrent B Acute Lymphoblastic Leukemia; Recurrent Burkitt Lymphoma; Refractory B Acute Lymphoblastic Leukemia; Refractory Burkitt Lymphoma |
M.D. Anderson Cancer Center |
2011-08-26 | PHASE1; PHASE2 |
| NCT01424982 | ACTIVE_NOT_RECRUITING | Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Acute Lymphoblastic Leukemia; Adult Acute Lymphoblastic Leukemia in Complete Remission; B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1; Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Philadelphia Chromosome Positive; Untreated Adult Acute Lymphoblastic Leukemia |
M.D. Anderson Cancer Center |
2011-10-05 | PHASE2 |
| NCT06692452 | WITHDRAWN | Lymphoma; Peripheral T Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Enteropathy-Associated T-Cell Lymphoma; Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma |
Eric Jacobsen, MD |
2024-12-24 | PHASE2 |
| NCT03914625 | ACTIVE_NOT_RECRUITING | B Acute Lymphoblastic Leukemia; B Lymphoblastic Lymphoma; Down Syndrome |
National Cancer Institute (NCI) |
2019-07-03 | PHASE3 |
| NCT07444710 | NOT_YET_RECRUITING | Ann Arbor Stage II Mantle Cell Lymphoma; Ann Arbor Stage III Mantle Cell Lymphoma; Ann Arbor Stage IV Mantle Cell Lymphoma |
National Cancer Institute (NCI) |
2026-10-30 | PHASE1 |
| NCT04542824 | ACTIVE_NOT_RECRUITING | Diffuse Large B Cell Lymphoma; High-grade B-cell Lymphoma; Primary Mediastinal Large B Cell Lymphoma; Follicular Lymphoma; Marginal Zone Lymphoma; Small Lymphocytic Lymphoma |
Genmab |
2020-08-20 | PHASE1; PHASE2 |
| NCT03136146 | RECRUITING | Recurrent Acute Lymphoblastic Leukemia; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Burkitt Leukemia; Recurrent Burkitt Lymphoma; Recurrent Childhood Lymphoblastic Lymphoma; Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; Refractory Acute Lymphoblastic Leukemia; Refractory Burkitt Leukemia; Refractory Burkitt Lymphoma; Refractory High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; Refractory Lymphoblastic Lymphoma |
M.D. Anderson Cancer Center |
2017-08-09 | PHASE2 |
| NCT06630091 | RECRUITING | Peripheral T Cell Lymphoma |
M.D. Anderson Cancer Center |
2025-02-21 | PHASE2 |
| NCT04322318 | RECRUITING | Anaplastic Kidney Wilms Tumor; Recurrent Kidney Wilms Tumor; Stage II Kidney Wilms Tumor; Stage III Kidney Wilms Tumor; Stage IV Kidney Wilms Tumor |
Children's Oncology Group |
2020-10-19 | PHASE2 |
| NCT05279300 | SUSPENDED | Advanced Solid Tumor; Advanced Lymphoma |
CStone Pharmaceuticals |
2022-03-28 | PHASE1 |
| NCT04301076 | RECRUITING | Acute Adult T-Cell Leukemia/Lymphoma; Adult T-Cell Leukemia/Lymphoma; Chronic Adult T-Cell Leukemia/Lymphoma; HTLV-1 Infection |
National Cancer Institute (NCI) |
2021-08-31 | PHASE1 |
| NCT05578976 | ACTIVE_NOT_RECRUITING | Diffuse Large B-Cell Lymphoma |
Genmab |
2023-02-08 | PHASE3 |
| NCT06421948 | RECRUITING | Peripheral T-cell Lymphoma |
Yanyan Liu |
2024-05-25 | PHASE1; PHASE2 |
| NCT04803201 | RECRUITING | Angioimmunoblastic T-cell Lymphoma; Enteropathy-Associated T-Cell Lymphoma; Follicular T-Cell Lymphoma; Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma; Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma; Nodal Peripheral T-Cell Lymphoma With TFH Phenotype; Peripheral T-Cell Lymphoma, Not Otherwise Specified |
Alliance for Clinical Trials in Oncology |
2021-10-08 | PHASE2 |
| NCT07092306 | NOT_YET_RECRUITING | Ewing's Sarcoma |
Tang Xiaodong |
2025-08-10 | PHASE2 |
| NCT07081022 | ACTIVE_NOT_RECRUITING | B-cell Non-Hodgkin's Lymphoma |
Shanghai Junshi Bioscience Co., Ltd. |
2025-08-17 | PHASE2 |
| NCT03533582 | ACTIVE_NOT_RECRUITING | Childhood Hepatocellular Carcinoma; Childhood Malignant Liver Neoplasm; Fibrolamellar Carcinoma; Hepatoblastoma; Hepatocellular Malignant Neoplasm, Not Otherwise Specified |
Children's Oncology Group |
2018-05-24 | PHASE3 |
| NCT04478292 | RECRUITING | Hepatoblastoma |
Shanghai Children's Medical Center |
2021-03-01 | PHASE3 |
| NCT03710772 | ACTIVE_NOT_RECRUITING | Mantle Cell Lymphoma |
M.D. Anderson Cancer Center |
2019-05-01 | PHASE2 |
| NCT01837862 | ACTIVE_NOT_RECRUITING | Pilomyxoid Astrocytoma; Pilocytic Astrocytoma; Glioma, Astrocytic; Optic Nerve Glioma; Pleomorphic Xanthoastrocytoma; Glioblastoma Multiforme; Anaplastic Astrocytoma; Gliosarcoma; Diffuse Intrinsic Pontine Glioma; DIPG; Low-grade Glioma; Brainstem Glioma |
Julie Krystal |
2013-10-22 | PHASE1; PHASE2 |
| NCT04529772 | ACTIVE_NOT_RECRUITING | Diffuse Large B-Cell Lymphoma |
Acerta Pharma BV |
2020-10-08 | PHASE3 |
| NCT04978584 | ACTIVE_NOT_RECRUITING | Diffuse Large B-Cell Lymphoma |
M.D. Anderson Cancer Center |
2022-03-03 | PHASE2 |
| NCT03755804 | ACTIVE_NOT_RECRUITING | Hodgkin Lymphoma |
St. Jude Children's Research Hospital |
2018-12-12 | PHASE2 |
| NCT04759586 | ACTIVE_NOT_RECRUITING | Primary Mediastinal Large B-Cell Lymphoma |
National Cancer Institute (NCI) |
2021-10-05 | PHASE3 |
| NCT05681260 | RECRUITING | T-cell Lymphoblastic Lymphoma |
Children's Cancer Group, China |
2023-02-06 | PHASE3 |
| NCT02981628 | ACTIVE_NOT_RECRUITING | Recurrent B Acute Lymphoblastic Leukemia; Recurrent B Lymphoblastic Lymphoma; Refractory B Acute Lymphoblastic Leukemia; Refractory B Lymphoblastic Lymphoma |
Children's Oncology Group |
2017-06-19 | PHASE2 |
| NCT04638790 | RECRUITING | Hodgkin Lymphoma, Adult |
State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia |
2020-02-01 | PHASE3 |
| NCT04890093 | SUSPENDED | Sarcoma, Ewing; Rhabdomyosarcoma |
National Cancer Institute (NCI) |
2024-10-31 | PHASE1; PHASE2 |
| NCT06387121 | RECRUITING | Precursor Cell Lymphoblastic Leukemia-Lymphoma |
Institute of Hematology & Blood Diseases Hospital, China |
2024-04-02 | PHASE2 |
| NCT06207123 | RECRUITING | Acute Leukemia; Lymphoblastic Leukemia; Lymphoblastic Lymphoma |
University of Chicago |
2024-09-13 | PHASE1; PHASE2 |
| NCT01871766 | ACTIVE_NOT_RECRUITING | Rhabdomyosarcoma |
St. Jude Children's Research Hospital |
2013-12-04 | PHASE2 |
| NCT02877303 | RECRUITING | B Acute Lymphoblastic Leukemia; B Lymphoblastic Lymphoma |
M.D. Anderson Cancer Center |
2016-11-01 | PHASE2 |
| NCT00501826 | RECRUITING | T Acute Lymphoblastic Leukemia; T Lymphoblastic Lymphoma |
M.D. Anderson Cancer Center |
2007-07-11 | PHASE2 |
| NCT05455697 | ACTIVE_NOT_RECRUITING | Diffuse Large B-Cell Lymphoma; Grade 3b Follicular Lymphoma; High Grade B-Cell Lymphoma |
University of Washington |
2023-01-26 | PHASE1; PHASE2 |
| NCT06977711 | RECRUITING | Diffuse Large B-cell Lymphoma |
The University of Texas Health Science Center at San Antonio |
2025-06-20 | PHASE1 |
| NCT03117751 | ACTIVE_NOT_RECRUITING | Acute Lymphoblastic Leukemia; Acute Lymphoblastic Lymphoma |
St. Jude Children's Research Hospital |
2017-03-29 | PHASE2; PHASE3 |
| NCT06210750 | WITHDRAWN | T Acute Lymphoblastic Leukemia; T Lymphoblastic Lymphoma |
National Cancer Institute (NCI) |
2024-08-09 | PHASE2 |
| NCT05521087 | WITHDRAWN | Acute Leukemias; Acute Myeloid Leukemia; Acute Lymphoblastic Leukemia; Acute Leukemia of Ambiguous Lineage |
Janssen Research & Development, LLC |
2025-12-26 | PHASE1 |
| NCT06514313 | RECRUITING | Soft Tissue Sarcoma |
Yizhuo Zhang |
2024-07-03 | PHASE2 |
| NCT04388839 | ACTIVE_NOT_RECRUITING | Rhabdomyosarcoma |
H. Lee Moffitt Cancer Center and Research Institute |
2020-12-29 | PHASE2 |
| NCT06005870 | RECRUITING | Diffuse Large B Cell Lymphoma |
Huazhong University of Science and Technology |
2022-11-26 | PHASE2 |
| NCT05457829 | RECRUITING | Rhabdomyosarcoma, Child |
Sun Yat-sen University |
2023-12-30 | PHASE2 |
| NCT04994132 | ACTIVE_NOT_RECRUITING | Alveolar Rhabdomyosarcoma; Botryoid-Type Embryonal Rhabdomyosarcoma; Embryonal Rhabdomyosarcoma; Metastatic Embryonal Rhabdomyosarcoma; Metastatic Rhabdomyosarcoma; Solid Alveolar Rhabdomyosarcoma; Spindle Cell Rhabdomyosarcoma; Spindle Cell/Sclerosing Rhabdomyosarcoma |
Children's Oncology Group |
2021-09-14 | PHASE3 |
| NCT06820957 | ACTIVE_NOT_RECRUITING | CIC-Rearranged Sarcoma; Metastatic Ewing Sarcoma; Metastatic High Grade Sarcoma; Metastatic Undifferentiated Round Cell Sarcoma; Metastatic Undifferentiated Sarcoma, Not Otherwise Specified; Round Cell Sarcoma With EWSR1-non-ETS Fusion; Sarcoma With BCOR Genetic Alterations |
Children's Oncology Group |
2025-11-10 | PHASE2; PHASE3 |
| NCT04850495 | ACTIVE_NOT_RECRUITING | Diffuse Large B-Cell Lymphoma; Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma; Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma |
Yazeed Sawalha |
2021-11-16 | PHASE1 |
| NCT05351346 | UNKNOWN | Diffuse Large B Cell Lymphoma |
Ruijin Hospital |
2022-06-01 | PHASE3 |
| NCT03758989 | RECRUITING | DLBCL |
University of Rochester |
2019-05-08 | PHASE2 |
| NCT06701344 | NOT_YET_RECRUITING | Enteropathy Associated T Cell Lymphoma |
Ruijin Hospital |
2024-12-04 | PHASE2 |
| NCT06700798 | RECRUITING | Marginal Zone Lymphoma(MZL) |
Fei Li |
2024-12-01 | PHASE2 |
| NCT05934097 | WITHDRAWN | Diffuse Large B Cell Lymphoma; Transformed Indolent Non-Hodgkin's Lymphoma; Follicular Lymphoma; Mantle Cell Lymphoma; Marginal Zone Lymphoma |
Fate Therapeutics |
2022-12 | PHASE1 |
| NCT05453500 | ACTIVE_NOT_RECRUITING | B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative |
University of Washington |
2023-03-27 | PHASE2 |
| NCT02723994 | COMPLETED | Leukemia |
Incyte Corporation |
2016-09-30 | PHASE2 |
| NCT03749018 | ACTIVE_NOT_RECRUITING | Aggressive Non-Hodgkin Lymphoma; Ann Arbor Stage I Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma; Ann Arbor Stage II B-Cell Non-Hodgkin Lymphoma; Ann Arbor Stage II Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma; Ann Arbor Stage III B-Cell Non-Hodgkin Lymphoma; Ann Arbor Stage III Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma; Ann Arbor Stage IV B-Cell Non-Hodgkin Lymphoma; Ann Arbor Stage IV Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma; Diffuse Large B-Cell Lymphoma; High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements; High Grade B-Cell Lymphoma, Not Otherwise Specified; Indolent Non-Hodgkin Lymphoma; Mediastinal B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma; Transformed Non-Hodgkin Lymphoma |
David Bond, MD |
2019-01-02 | PHASE2 |
| NCT06921044 | NOT_YET_RECRUITING | Diffuse Large B-Cell Lymphoma |
Xiaohui He |
2025-04-16 | PHASE2 |
| NCT03269669 | ACTIVE_NOT_RECRUITING | Grade 1 Follicular Lymphoma; Grade 2 Follicular Lymphoma; Grade 3a Follicular Lymphoma; Recurrent Follicular Lymphoma; Refractory Follicular Lymphoma |
National Cancer Institute (NCI) |
2018-01-23 | PHASE2 |
| NCT06710821 | NOT_YET_RECRUITING | Solid Tumor Cancer |
Yizhuo Zhang |
2024-12-01 | PHASE1 |
| NCT01464606 | ACTIVE_NOT_RECRUITING | Pleuropulmonary Blastoma |
Children's Hospitals and Clinics of Minnesota |
2009-12-22 | |
| NCT04835870 | UNKNOWN | Non-GCB/ABC Diffuse Large B-Cell Lymphoma |
The First Affiliated Hospital of Soochow University |
2021-04-01 | PHASE2 |
| NCT05422066 | UNKNOWN | DLBCL Germinal Center B-Cell Type |
Li Zhiming |
2022-07-26 | PHASE2 |
| NCT05051891 | COMPLETED | Treatment-naїve Mantle Cell Lymphoma |
Beijing InnoCare Pharma Tech Co., Ltd. |
2021-12-22 | PHASE3 |
| NCT06760117 | RECRUITING | Pediatric Solid Tumor |
Sun Yat-sen University |
2022-01-01 | PHASE1 |
| NCT05270057 | ACTIVE_NOT_RECRUITING | B-cell Lymphoma; Burkitt Lymphoma |
Medical College of Wisconsin |
2023-01-26 | PHASE1 |
| NCT05201248 | ACTIVE_NOT_RECRUITING | B-Cell Non-Hodgkin Lymphoma |
Genmab |
2022-03-10 | PHASE1; PHASE2 |
| NCT05238064 | UNKNOWN | PI3Kδ Inhibitor; Parsaclisib; CHOP; PTCL |
Fudan University |
2022-03 | PHASE1; PHASE2 |
| NCT03399747 | UNKNOWN | Diffuse Large B-cell Lymphoma |
Asan Medical Center |
2016-12-07 | PHASE2 |
| NCT04432714 | RECRUITING | DLBCL; Untreated; MYC Gene Rearrangement |
The First Affiliated Hospital with Nanjing Medical University |
2020-06-09 | PHASE1; PHASE2 |
| NCT05458180 | UNKNOWN | Peripheral T-cell Lymphoma |
Tianjin Medical University Cancer Institute and Hospital |
2022-07-07 | PHASE1 |
| NCT02881086 | COMPLETED | Acute Lymphoblastic Leukemia; Lymphoblastic Lymphoma |
Goethe University |
2016-08 | PHASE3 |
| NCT03220022 | ACTIVE_NOT_RECRUITING | AIDS-Related Lymphoma; Ann Arbor Stage II Diffuse Large B-Cell Lymphoma; Ann Arbor Stage III Diffuse Large B-Cell Lymphoma; Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma |
National Cancer Institute (NCI) |
2018-03-16 | PHASE1 |
| NCT02911142 | ACTIVE_NOT_RECRUITING | Primary Effusion Lymphoma; B-Cell Neoplasm |
National Cancer Institute (NCI) |
2017-07-03 | PHASE1; PHASE2 |
| NCT05656222 | WITHDRAWN | Objective Response; Overall Survival |
Peking University People's Hospital |
2021-08-01 | |
| NCT04980222 | ACTIVE_NOT_RECRUITING | Lymphoma |
Hoffmann-La Roche |
2022-03-22 | PHASE2 |
| NCT05620862 | UNKNOWN | Pediatric Solid Tumor |
Sun Yat-sen University |
2022-10-25 | PHASE1 |
| NCT05887726 | UNKNOWN | Diffuse Large B Cell Lymphoma |
Liaoning Cancer Hospital & Institute |
2023-08-01 | PHASE2 |
| NCT05990985 | UNKNOWN | Diffuse Large B-cell Lymphoma |
The First Hospital of Jilin University |
2023-09-01 | |
| NCT00878254 | COMPLETED | Mantle-Cell Lymphoma |
University of Miami |
2009-03-25 | PHASE2 |
| NCT03505762 | ACTIVE_NOT_RECRUITING | B-Cell Non-Hodgkin Lymphoma |
Wake Forest University Health Sciences |
2018-07-19 | PHASE2 |
| NCT04974996 | WITHDRAWN | Diffuse Large B-Cell Lymphoma |
ADC Therapeutics S.A. |
2022-02-01 | PHASE1 |
| NCT00390793 | COMPLETED | Acute Lymphoblastic Leukemia; BCR-ABL1 Fusion Protein Expression; Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Philadelphia Chromosome Positive; Recurrent Acute Lymphoblastic Leukemia; t(9;22) |
M.D. Anderson Cancer Center |
2006-09-28 | PHASE2 |
| NCT05200312 | UNKNOWN | Non Hodgkin Lymphoma; Diffuse Large B Cell Lymphoma |
The First Affiliated Hospital with Nanjing Medical University |
2022-02-01 | PHASE2 |
| NCT04922567 | RECRUITING | Peripheral T-Cell Lymphoma; Lenalidomide; CHOP |
Second Affiliated Hospital, Zhejiang University, School of Medicine |
2021-04-01 | PHASE2 |
| NCT04214626 | COMPLETED | Diffuse Large B Cell Lymphoma |
Henan Cancer Hospital |
2020-01-05 | PHASE2 |
| NCT04842487 | UNKNOWN | DLBCL |
Sun Yat-sen University |
2021-04-10 | PHASE2 |
| NCT04914741 | UNKNOWN | Diffuse Large B Cell Lymphoma; High-grade B-cell Lymphoma |
Peter MacCallum Cancer Centre, Australia |
2021-06-29 | PHASE1; PHASE2 |
| NCT03817320 | ACTIVE_NOT_RECRUITING | ALL, Childhood; Lymphoblastic Lymphoma, Childhood; Lymphoblastic Leukemia, Acute, Childhood |
Therapeutic Advances in Childhood Leukemia Consortium |
2019-02-12 | PHASE1; PHASE2 |
| NCT03677141 | COMPLETED | B-cell Non-Hodgkin Lymphoma |
Hoffmann-La Roche |
2019-03-08 | PHASE1; PHASE2 |
| NCT05008224 | COMPLETED | Classical Hodgkin Lymphoma |
Merck Sharp & Dohme LLC |
2021-10-07 | PHASE2 |
| NCT02626455 | TERMINATED | Lymphoma, Non-Hodgkin |
Bayer |
2016-01-06 | PHASE3 |
| NCT05777369 | UNKNOWN | Diffuse Large B-cell Lymphoma |
The First Affiliated Hospital with Nanjing Medical University |
2023-03 | |
| NCT02348216 | COMPLETED | Refractory Diffuse Large B Cell Lymphoma (DLBCL); Relapsed Diffuse Large B-Cell Lymphoma; Transformed Follicular Lymphoma (TFL); Primary Mediastinal B-cell Lymphoma (PMBCL); High Grade B-cell Lymphoma (HGBCL) |
Kite, A Gilead Company |
2015-04-21 | PHASE1; PHASE2 |
| NCT03864419 | TERMINATED | Burkitt Lymphoma; KSHV-associated Multicentric Castleman Disease; Diffuse Large B-Cell Lymphoma |
Fred Hutchinson Cancer Center |
2019-10-24 | PHASE1 |
| NCT04659421 | COMPLETED | Low-grade Glioma; Pediatric Brain Tumor |
Beijing Sanbo Brain Hospital |
2020-11-03 | PHASE2 |
| NCT04773366 | UNKNOWN | Langerhans Cell Histiocytosis |
Shanghai Children's Medical Center |
2018-07-01 | PHASE3 |
| NCT02567435 | ACTIVE_NOT_RECRUITING | Alveolar Rhabdomyosarcoma; Botryoid-Type Embryonal Rhabdomyosarcoma; Embryonal Rhabdomyosarcoma; Rhabdomyosarcoma; Sclerosing Rhabdomyosarcoma; Spindle Cell Rhabdomyosarcoma |
National Cancer Institute (NCI) |
2016-06-01 | PHASE3 |
| NCT04448834 | WITHDRAWN | B-cell Acute Lymphoblastic Leukemia |
Dorothy Sipkins, MD, PhD |
2022-01 | PHASE2 |
| NCT05425654 | UNKNOWN | Primary CNS Lymphoma |
National Research Center for Hematology, Russia |
2021-05-17 | PHASE2 |
| NCT04480099 | UNKNOWN | Peripheral T-cell Lymphoma |
Ruijin Hospital |
2020-07-29 | PHASE2 |
| NCT05844670 | Recruiting | Pediatric Cancer |
Moi University|Princess Maxima Center for Pediatric Oncology|Amsterdam UMC location VUmc |
2023-04-20 | Phase 4 |
| NCT04842318 | UNKNOWN | Follicular Lymphoma |
Ruijin Hospital |
2021-03-01 | PHASE4 |
| NCT00596154 | COMPLETED | CNS Lymphoma; CNS Brain Cancer; Non-Hodgkin's Lymphoma |
Memorial Sloan Kettering Cancer Center |
2004-12 | PHASE2 |
| NCT02661503 | UNKNOWN | Classical Hodgkin Lymphoma |
University of Cologne |
2016-07 | PHASE3 |
| NCT02752815 | UNKNOWN | Diffuse Large B-cell Lymphoma |
Ruijin Hospital |
2016-06-14 | PHASE4 |
| NCT02636322 | COMPLETED | Diffuse Large B-Cell Lymphoma Unclassifiable |
M.D. Anderson Cancer Center |
2016-03-29 | PHASE2 |
| NCT03991884 | COMPLETED | Recurrent B Acute Lymphoblastic Leukemia; Recurrent B Lymphoblastic Lymphoma; Refractory B Acute Lymphoblastic Leukemia; Refractory B Lymphoblastic Lymphoma |
University of Washington |
2019-09-24 | PHASE1 |
| NCT03589326 | ACTIVE_NOT_RECRUITING | Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL) |
Takeda |
2018-10-04 | PHASE3 |
| NCT02398240 | COMPLETED | Hodgkin Lymphoma |
Mitchell Cairo |
2015-05 | PHASE2 |
| NCT01974440 | COMPLETED | Lymphoma |
Janssen Research & Development, LLC |
2014-01-31 | PHASE3 |
| NCT04660799 | COMPLETED | Lymphoma, Large B-Cell, Diffuse |
Hoffmann-La Roche |
2021-02-24 | PHASE2 |
| NCT02553460 | ACTIVE_NOT_RECRUITING | Acute Lymphoblastic Leukemia |
St. Jude Children's Research Hospital |
2016-01-29 | PHASE1; PHASE2 |
| NCT03003520 | COMPLETED | Lymphoma, Large B-Cell, Diffuse |
Celgene |
2017-02-28 | PHASE2 |
| NCT01925131 | COMPLETED | Acute Leukemias of Ambiguous Lineage; B-cell Adult Acute Lymphoblastic Leukemia; Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Adult Burkitt Lymphoma |
SWOG Cancer Research Network |
2014-06-13 | PHASE1 |
| NCT04448834 | Withdrawn | B-cell Acute Lymphoblastic Leukemia |
Dorothy Sipkins MD PhD|Amgen|Acrotech Biopharma Inc.|Duke University |
2022-01 | Phase 2 |
| NCT02523976 | COMPLETED | Acute,Leukemia, Lymphoid |
Institute of Hematology & Blood Diseases Hospital, China |
2015-08-01 | PHASE2 |
| NCT02166463 | ACTIVE_NOT_RECRUITING | Ann Arbor Stage IIB Hodgkin Lymphoma; Ann Arbor Stage IIIB Hodgkin Lymphoma; Ann Arbor Stage IVA Hodgkin Lymphoma; Ann Arbor Stage IVB Hodgkin Lymphoma; Childhood Hodgkin Lymphoma; Classic Hodgkin Lymphoma |
National Cancer Institute (NCI) |
2015-03-19 | PHASE3 |
| NCT02918747 | UNKNOWN | Lymphoma |
Hunan Cancer Hospital |
2016-09 | PHASE2 |
| NCT02684058 | COMPLETED | Diffuse Astrocytoma; Anaplastic Astrocytoma; Astrocytoma; Oligodendroglioma, Childhood; Anaplastic Oligodendroglioma; Glioblastoma; Pilocytic Astrocytoma; Giant Cell Astrocytoma; Pleomorphic Xanthoastrocytoma; Anaplastic Pleomorphic Xanthoastrocytoma; Angiocentric Glioma; Chordoid Glioma of Third Ventricle; Gangliocytoma; Ganglioglioma; Anaplastic Ganglioglioma; Dysplastic Gangliocytoma of Cerebrellum; Desmoplastic Infantile Astrocytoma and Ganglioglioma; Papillary Glioneuronal Tumor; Rosette-forming Glioneurona Tumor; Central Neurocytoma; Extraventricular Neurocytoma; Cerebellar Iponeurocytoma |
Novartis Pharmaceuticals |
2017-12-28 | PHASE2 |
| NCT03349281 | COMPLETED | Refractory Acute Lymphoblastic Leukemia; Relapsed Acute Lymphoblastic Leukemia |
Julio Barredo, MD |
2019-03-25 | PHASE1 |
| NCT03792256 | COMPLETED | Leukemia, Lymphocytic; Lymphoblastic Lymphoma; T-cell Lymphoma; T-cell Leukemia; Recurrent Disease; Acute Leukemia |
Children's Oncology Group |
2019-04-11 | PHASE1 |
| NCT03564704 | UNKNOWN | Leukemia; Leukemia, Acute; Adult Lymphoblastic Lymphoma; Leukemia, Lymphoblastic; Leukemia, T Cell; Adult Acute Lymphoblastic Leukemia; Lymphoblastic Lymphoma; Lymphoblastic Leukemia |
Nanfang Hospital, Southern Medical University |
2016-02-14 | PHASE2; PHASE3 |
| NCT03688633 | TERMINATED | Peripheral Neuropathy |
University Hospital, Limoges |
2019-05-01 | PHASE2 |
| NCT00670358 | COMPLETED | Lymphoma |
Mayo Clinic |
2008-08-25 | PHASE1; PHASE2 |
| NCT03892330 | NOT_YET_RECRUITING | 0.5-14 Year Old Children With Nephroblastoma |
Shengjing Hospital |
2019-06-01 | PHASE4 |
| NCT03613428 | UNKNOWN | Acute T Cell Leukemia |
Sichuan University |
2018-12-01 | PHASE1; PHASE2 |
| NCT01920932 | ACTIVE_NOT_RECRUITING | Stage II Childhood Hodgkin Lymphoma; Stage III Childhood Hodgkin Lymphoma; Stage IV Childhood Hodgkin Lymphoma |
St. Jude Children's Research Hospital |
2013-08-12 | PHASE2 |
| NCT01319981 | COMPLETED | Leukemia |
M.D. Anderson Cancer Center |
2013-03-05 | PHASE2 |
| NCT00477412 | COMPLETED | Mantle Cell Lymphoma |
M.D. Anderson Cancer Center |
2007-04-03 | PHASE1; PHASE2 |
| NCT03617432 | UNKNOWN | Experimental Tumor |
Peking University |
2018-08-28 | PHASE2 |
| NCT00549848 | COMPLETED | Acute Lymphoblastic Leukemia |
St. Jude Children's Research Hospital |
2007-10-29 | PHASE3 |
| NCT01542736 | COMPLETED | Metastatic Medulloblastoma; High Risk Supratentorial PNET; Metastatic PNET |
University of Colorado, Denver |
2007-05 | PHASE2 |
| NCT02257242 | COMPLETED | Lymphoma, Non-Hodgkin; Lymphoma, Follicular; Lymphoma, Mantle-Cell; Lymphoma, Small-Cell; Waldenstrom Macroglobulinemia; Lymphoma, B-Cell, Marginal Zone |
Brown University |
2017-05-10 | PHASE1 |
| NCT04243434 | UNKNOWN | Hematologic Diseases |
Acrotech Biopharma Inc. |
2020-08-15 | PHASE1 |
| NCT03268889 | UNKNOWN | Peripheral T Cell Lymphoma |
The First Affiliated Hospital of Soochow University |
2017-06-15 | |
| NCT01359592 | COMPLETED | Lymphoma |
SWOG Cancer Research Network |
2011-09 | PHASE2 |
| NCT02670616 | COMPLETED | Epstein-Barr Virus-positive Diffuse Large B-cell Lymphoma |
Samsung Medical Center |
2016-05-01 | PHASE2 |
| NCT01363128 | COMPLETED | Acute Lymphoblastic Leukemia; Adult Acute Lymphoblastic Leukemia in Complete Remission; Burkitt Leukemia; Burkitt Lymphoma; CD20 Positive; Childhood Acute Lymphoblastic Leukemia in Complete Remission; Lymphoblastic Lymphoma |
M.D. Anderson Cancer Center |
2011-07-12 | PHASE2 |
| NCT01856192 | ACTIVE_NOT_RECRUITING | Ann Arbor Stage II Diffuse Large B-Cell Lymphoma; Ann Arbor Stage III Diffuse Large B-Cell Lymphoma; Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma |
National Cancer Institute (NCI) |
2013-08-27 | PHASE2 |
| NCT01356680 | COMPLETED | Hodgkin Lymphoma |
University of Cologne |
2012-01-13 | PHASE3 |
| NCT03018626 | UNKNOWN | Lymphoma, Large B-Cell, Diffuse |
Nanfang Hospital, Southern Medical University |
2017-07-27 | PHASE3 |
| NCT02036489 | COMPLETED | Acute Lymphobkastic Leukemia |
PETHEMA Foundation |
2008-01 | PHASE4 |
| NCT02858804 | COMPLETED | Mantle Cell Lymphoma |
Institute of Hematology & Blood Diseases Hospital, China |
2016-01 | PHASE4 |
| NCT00058422 | COMPLETED | Lymphoma |
Memorial Sloan Kettering Cancer Center |
2003-02-10 | PHASE2 |
| NCT02110069 | TERMINATED | Kaposiform Hemangioendothelioma (KHE); Kasabach-Merritt Syndrome; Tufted Angioma |
Boston Children's Hospital |
2017-06-14 | PHASE2 |
| NCT02449278 | UNKNOWN | Diffuse Large B-cell Lymphoma |
Wuhan University |
2015-10 | PHASE3 |
| NCT01528046 | COMPLETED | Solid Tumors; Primary Brain Tumors |
H. Lee Moffitt Cancer Center and Research Institute |
2012-09-24 | PHASE1 |
| NCT00392327 | COMPLETED | Anaplastic Medulloblastoma; Medulloblastoma |
Children's Oncology Group |
2007-05-23 | PHASE3 |
| NCT00945724 | COMPLETED | Large B-cell Diffuse Lymphoma of Testis |
International Extranodal Lymphoma Study Group (IELSG) |
2009-09-27 | PHASE2 |
| NCT01889069 | COMPLETED | Lymphoma |
Hoffmann-La Roche |
2013-07-31 | PHASE3 |
| NCT02116959 | TERMINATED | Advanced Intra-Ocular Retinoblastoma; Retinoblastoma |
University of California, San Francisco |
2014-07-23 | PHASE1 |
| NCT02951728 | UNKNOWN | Diffuse Large B Cell Lymphoma |
Ruijin Hospital |
2016-10 | PHASE1; PHASE2 |
| NCT01190930 | COMPLETED | Acute Lymphoblastic Leukemia; Adult B Lymphoblastic Lymphoma; Ann Arbor Stage I B Lymphoblastic Lymphoma; Ann Arbor Stage II B Lymphoblastic Lymphoma; Childhood B Acute Lymphoblastic Leukemia; Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1; Childhood B Lymphoblastic Lymphoma; Down Syndrome; Hypodiploid B Acute Lymphoblastic Leukemia; Philadelphia Chromosome Positive |
Children's Oncology Group |
2010-08-11 | PHASE3 |
| NCT02285062 | COMPLETED | Lymphoma, Large B-Cell, Diffuse |
Celgene |
2015-02-17 | PHASE3 |
| NCT03593304 | COMPLETED | Vincristine Induced Neurotoxicity; Acute Lymphoblastic Leukaemia |
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh |
2018-03-29 | PHASE2; PHASE3 |
| NCT02541565 | COMPLETED | Composite Lymphoma; Grade 3b Follicular Lymphoma; Stage I Diffuse Large B-Cell Lymphoma; Stage I Follicular Lymphoma; Stage II Diffuse Large B-Cell Lymphoma; Stage II Follicular Lymphoma; Stage III Diffuse Large B-Cell Lymphoma; Stage III Follicular Lymphoma; Stage IV Diffuse Large B-Cell Lymphoma; Stage IV Follicular Lymphoma |
University of Washington |
2015-11-24 | PHASE1 |
| NCT02404220 | TERMINATED | Acute Lymphoblastic Leukemia |
Gilead Sciences |
2015-05-06 | PHASE1; PHASE2 |
| NCT02212574 | TERMINATED | Medulloblastoma |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2017-04-04 | EARLY_PHASE1 |
| NCT00707083 | COMPLETED | Leukemia |
Prince of Wales Hospital, Shatin, Hong Kong |
2008-05-01 | PHASE3 |
| NCT02894645 | UNKNOWN | Acute Lymphoblastic Leukemia (ALL) |
National University Hospital, Singapore |
2008-10 | PHASE4 |
| NCT00115700 | COMPLETED | Follicular Lymphoma |
Trans Tasman Radiation Oncology Group |
2000-02 | PHASE3 |
| NCT00278421 | COMPLETED | Lymphoma |
German High-Grade Non-Hodgkin's Lymphoma Study Group |
2005-11 | PHASE3 |
| NCT00866749 | COMPLETED | Lymphoblastic Leukemia; Lymphoblastic Lymphoma |
M.D. Anderson Cancer Center |
2006-09-12 | PHASE2 |
| NCT02861040 | WITHDRAWN | Recurrent Adult Acute Lymphoblastic Leukemia; Refractory Adult Acute Lymphoblastic Leukemia |
Northwestern University |
2016-08 | PHASE1 |
| NCT00554788 | COMPLETED | Extraocular Retinoblastoma |
Children's Oncology Group |
2008-05-06 | PHASE3 |
| NCT03188198 | UNKNOWN | Large B Cell Lymphoma |
Mansoura University |
2016-06-01 | PHASE2 |
| NCT02923388 | COMPLETED | Vincristine Induced Peripheral Neuropathy (VIPN) |
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh |
2016-10 | PHASE4 |
| NCT01355445 | COMPLETED | RHABDOMYOSARCOMA |
Centre Oscar Lambret |
2012-01 | PHASE2 |
| NCT01435018 | COMPLETED | HIV-1 Infection |
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections |
2013-10-01 | PHASE3 |
| NCT01622439 | COMPLETED | Diffuse Large B-cell Lymphoma |
Lund University Hospital |
2012-06 | PHASE1; PHASE2 |
| NCT00278408 | COMPLETED | Lymphoma |
German High-Grade Non-Hodgkin's Lymphoma Study Group |
2006-01-02 | PHASE3 |
| NCT01506453 | COMPLETED | Acute Lymphoblastic Leukemia; Neuropathy; Neuropathic Pain |
St. Jude Children's Research Hospital |
2012-01-24 | PHASE2 |
| NCT00500890 | TERMINATED | Choroid Plexus Tumors |
M.D. Anderson Cancer Center |
2005-09-02 | PHASE3 |
| NCT02293109 | COMPLETED | Contiguous Stage II Adult Lymphoblastic Lymphoma; Noncontiguous Stage II Adult Lymphoblastic Lymphoma; Stage I Adult Lymphoblastic Lymphoma; Stage III Adult Lymphoblastic Lymphoma; Stage IV Adult Lymphoblastic Lymphoma; Untreated Adult Acute Lymphoblastic Leukemia |
Mehrdad Abedi, MD |
2015-12-17 | PHASE1 |
| NCT01156883 | COMPLETED | Leukemia |
Gruppo Italiano Malattie EMatologiche dell'Adulto |
2010-04 | |
| NCT00408005 | COMPLETED | T Acute Lymphoblastic Leukemia; T Lymphoblastic Lymphoma |
National Cancer Institute (NCI) |
2007-01-30 | PHASE3 |
| NCT00801281 | COMPLETED | Follicular Lymphoma; Marginal Zone Lymphoma; Small Lymphocytic Lymphoma; Lymphoplasmacytic Lymphoma |
Polish Lymphoma Research Group |
2007-02 | PHASE3 |
| NCT02419469 | TERMINATED | Leukemia; Precursor-B Acute Lymphoblastic Leukemia; Lymphoblastic Lymphoma; Lymphoma |
M.D. Anderson Cancer Center |
2015-11-13 | PHASE2 |
| NCT02594267 | COMPLETED | Peripheral T-Cell Lymphoma (PTCL) |
Acrotech Biopharma Inc. |
2015-11-10 | PHASE1 |
| NCT01516567 | COMPLETED | Primary Mediastinal Large B Cell Lymphoma |
Gustave Roussy, Cancer Campus, Grand Paris |
2012-04-01 | PHASE2 |
| NCT02072785 | UNKNOWN | Adult Acute Lymphoblastic Leukemia |
Nanjing Luye Sike Pharmaceutical Co., Ltd. |
2013-06 | PHASE3 |
| NCT01523977 | COMPLETED | Acute Lymphoblastic Leukemia |
Dana-Farber Cancer Institute |
2011-11 | PHASE1 |
| NCT00336024 | COMPLETED | Anaplastic Medulloblastoma; Medulloblastoma; Supratentorial Embryonal Tumor, Not Otherwise Specified; Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor |
Children's Oncology Group |
2007-10-22 | PHASE3 |
| NCT01336933 | COMPLETED | Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Hepatosplenic T-cell Lymphoma; Peripheral T-cell Lymphoma |
University of Nebraska |
2011-07-06 | PHASE2 |
| NCT00085202 | COMPLETED | Brain and Central Nervous System Tumors |
St. Jude Children's Research Hospital |
2003-08 | PHASE3 |
| NCT02595242 | WITHDRAWN | Diffuse Large B Cell Lymphoma |
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. |
2015-06 | PHASE1 |
| NCT00526318 | UNKNOWN | Neuroblastoma |
German Society for Pediatric Oncology and Hematology GPOH gGmbH |
2007-01 | |
| NCT01193842 | COMPLETED | AIDS-Related Plasmablastic Lymphoma; AIDS-Related Primary Effusion Lymphoma; Ann Arbor Stage I Diffuse Large B-Cell Lymphoma; Ann Arbor Stage I Grade 3 Follicular Lymphoma; Ann Arbor Stage II Diffuse Large B-Cell Lymphoma; Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma; Ann Arbor Stage III Diffuse Large B-Cell Lymphoma; Ann Arbor Stage III Grade 3 Follicular Lymphoma; Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma; Ann Arbor Stage IV Grade 3 Follicular Lymphoma; HIV Infection; Plasmablastic Lymphoma; Primary Effusion Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Grade 3 Follicular Lymphoma |
National Cancer Institute (NCI) |
2010-10-06 | PHASE1; PHASE2 |
| NCT01219816 | COMPLETED | B ALL; CD22+ Expression; Refractory B-ALL |
Nantes University Hospital |
2010-11 | PHASE2 |
| NCT00653068 | COMPLETED | Childhood Atypical Teratoid/Rhabdoid Tumor |
Children's Oncology Group |
2009-02-10 | PHASE3 |
| NCT00558519 | COMPLETED | Leukemia |
Alliance for Clinical Trials in Oncology |
2008-03-12 | PHASE2 |
| NCT01535183 | UNKNOWN | Brain Tumor |
Seoul National University Hospital |
2012-01 | PHASE2 |
| NCT01279902 | UNKNOWN | Diffuse Large B-cell Lymphoma |
Asan Medical Center |
2010-08 | PHASE2 |
| NCT02531308 | TERMINATED | Diffuse Large B-Cell Lymphoma |
Rush University Medical Center |
2015-07 | PHASE2 |
| NCT00379340 | COMPLETED | Stage III Kidney Wilms Tumor; Stage IV Kidney Wilms Tumor |
Children's Oncology Group |
2007-04-30 | PHASE3 |
| NCT01055314 | COMPLETED | Adult Rhabdomyosarcoma; Childhood Alveolar Rhabdomyosarcoma; Childhood Embryonal Rhabdomyosarcoma; Metastatic Childhood Soft Tissue Sarcoma; Stage IV Adult Soft Tissue Sarcoma; Untreated Childhood Rhabdomyosarcoma |
National Cancer Institute (NCI) |
2010-01 | PHASE2 |
| NCT00450385 | TERMINATED | Lymphoma |
University of Miami |
2007-04-24 | PHASE2 |
| NCT00110110 | UNKNOWN | Retinoblastoma |
The Hospital for Sick Children |
2004-06 | PHASE2 |
| NCT02337478 | TERMINATED | Recurrent Adult Acute Myeloid Leukemia |
Wake Forest University Health Sciences |
2015-06-05 | PHASE2 |
| NCT00920153 | TERMINATED | Lymphoma |
French Innovative Leukemia Organisation |
2008-05 | PHASE3 |
| NCT00381680 | COMPLETED | B-cell Childhood Acute Lymphoblastic Leukemia; L1 Childhood Acute Lymphoblastic Leukemia; L2 Childhood Acute Lymphoblastic Leukemia; Intermediate Risk Recurrent Childhood Acute Lymphoblastic Leukemia |
Children's Oncology Group |
2007-03 | PHASE3 |
| NCT01332968 | COMPLETED | Non-Hodgkin's Lymphoma |
Hoffmann-La Roche |
2011-07-06 | PHASE3 |
| NCT01412879 | COMPLETED | Lymphoma |
SWOG Cancer Research Network |
2011-11 | PHASE2 |
| NCT00678327 | COMPLETED | Lymphoma |
University College, London |
2008-08-29 | PHASE3 |
| NCT02162771 | COMPLETED | Lymphoma, Follicular |
Celltrion |
2014-07-14 | PHASE3 |
| NCT01839097 | COMPLETED | Peripheral T-cell Lymphoma |
Acrotech Biopharma Inc. |
2013-05 | PHASE1 |
| NCT00972478 | ACTIVE_NOT_RECRUITING | Ann Arbor Stage II Non-Hodgkin Lymphoma; Ann Arbor Stage III Non-Hodgkin Lymphoma; Ann Arbor Stage IV Non-Hodgkin Lymphoma |
National Cancer Institute (NCI) |
2010-11-15 | PHASE1; PHASE2 |
| NCT01439347 | TERMINATED | Acute Lymphoblastic Leukemia (ALL) |
Spectrum Pharmaceuticals, Inc |
2012-03 | PHASE3 |
| NCT00634179 | COMPLETED | Lymphoma, B-Cell; Follicular Lymphoma |
Emory University |
2008-02 | PHASE1; PHASE2 |
| NCT00669877 | COMPLETED | Burkitt's Lymphoma; Burkitt'S-like Lymphoma |
M.D. Anderson Cancer Center |
2002-08 | PHASE2 |
| NCT01946529 | COMPLETED | Desmoplastic Small Round Cell Tumor; Ewing Sarcoma of Bone or Soft Tissue; Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor; Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor |
St. Jude Children's Research Hospital |
2013-12-27 | PHASE2 |
| NCT00931918 | COMPLETED | Non-Germinal B-Cell-like (GCB) Diffuse Large B-cell Lymphoma (DLBCL) |
Millennium Pharmaceuticals, Inc. |
2009-10 | PHASE2 |
| NCT01483690 | TERMINATED | Acute Lymphoblastic Leukemia; Precursor B-Cell Lymphoblastic Leukemia; Precursor T-Cell Lymphoblastic Leukemia |
Therapeutic Advances in Childhood Leukemia Consortium |
2011-12 | PHASE1; PHASE2 |
| NCT00450801 | COMPLETED | Lymphoma |
University of Miami |
2004-04 | PHASE2 |
| NCT00107198 | COMPLETED | Ann Arbor Stage I Childhood Hodgkin Lymphoma; Ann Arbor Stage II Childhood Hodgkin Lymphoma; Childhood Nodular Lymphocyte Predominant B-Cell Lymphoma |
Children's Oncology Group |
2006-03-10 | PHASE2 |
| NCT02228512 | WITHDRAWN | Large Cell Lymphoma Arising in KSHV-associated Multicentric Castleman Disease; Primary Effusion Lymphoma |
National Cancer Institute (NCI) |
2014-08-15 | PHASE1; PHASE2 |
| NCT00352027 | COMPLETED | Hodgkin's Lymphoma |
St. Jude Children's Research Hospital |
2006-07-20 | PHASE2 |
| NCT00526175 | COMPLETED | Acute Lymphoblastic Leukemia |
PETHEMA Foundation |
2001-06 | PHASE4 |
| NCT01403415 | COMPLETED | Childhood B Acute Lymphoblastic Leukemia; Childhood T Acute Lymphoblastic Leukemia; Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma; Recurrent Childhood Acute Lymphoblastic Leukemia; Recurrent Childhood Lymphoblastic Lymphoma |
National Cancer Institute (NCI) |
2011-09 | PHASE1 |
| NCT00567567 | COMPLETED | Localized Resectable Neuroblastoma; Localized Unresectable Neuroblastoma; Recurrent Neuroblastoma; Regional Neuroblastoma; Stage 4 Neuroblastoma; Stage 4S Neuroblastoma |
Children's Oncology Group |
2007-11-05 | PHASE3 |
| NCT01397825 | COMPLETED | Diffuse Large B-Cell Lymphoma; Transformed Follicular Lymphoma; Mantle Cell Lymphoma; Burkitt's Lymphoma |
Millennium Pharmaceuticals, Inc. |
2011-08-09 | PHASE1; PHASE2 |
| NCT00352534 | COMPLETED | Stage I Kidney Wilms Tumor; Stage II Kidney Wilms Tumor; Stage III Kidney Wilms Tumor |
Children's Oncology Group |
2006-11-06 | PHASE3 |
| NCT01255514 | COMPLETED | Multiple Myeloma |
Yonsei University |
2008-10-30 | PHASE2 |
| NCT00354835 | COMPLETED | Adult Rhabdomyosarcoma; Childhood Alveolar Rhabdomyosarcoma; Childhood Botryoid-Type Embryonal Rhabdomyosarcoma; Childhood Embryonal Rhabdomyosarcoma; Localized Childhood Soft Tissue Sarcoma; Rhabdomyosarcoma; Sarcoma; Stage I Adult Soft Tissue Sarcoma AJCC v7; Stage II Adult Soft Tissue Sarcoma AJCC v7; Stage III Adult Soft Tissue Sarcoma AJCC v7 |
Children's Oncology Group |
2006-12-26 | PHASE3 |
| NCT01222780 | COMPLETED | Sarcoma; Neuroblastoma; Wilms Tumor; Leukemia; Lymphoma; Brain Tumors |
Acrotech Biopharma Inc. |
2010-09 | PHASE1 |
| NCT00506142 | COMPLETED | Metastatic Malignant Uveal Melanoma |
Spectrum Pharmaceuticals, Inc |
2007-11 | PHASE2 |
| NCT00526409 | COMPLETED | Acute Lymphoblastic Leukemia |
PETHEMA Foundation |
2005-06 | PHASE4 |
| NCT01746173 | TERMINATED | T-cell Non-Hodgkin Lymphoma |
Dana-Farber Cancer Institute |
2013-07 | PHASE2 |
| NCT00051311 | COMPLETED | Hematologic Neoplasms |
National Cancer Institute (NCI) |
2003-01-03 | PHASE2 |
| NCT01569750 | COMPLETED | CD20-positive B-cell Non-Hodgkin Lymphoma |
Janssen Research & Development, LLC |
2012-06-14 | PHASE1 |
| NCT00101010 | COMPLETED | Lymphoma |
M.D. Anderson Cancer Center |
2005-09 | PHASE2 |
| NCT00400946 | COMPLETED | Drug/Agent Toxicity by Tissue/Organ; Leukemia |
Dana-Farber Cancer Institute |
2005-04 | PHASE3 |
| NCT01313884 | TERMINATED | Bone Cancer; Ewing's Sarcoma |
Stanford University |
2011-05 | PHASE2 |
| NCT00038610 | COMPLETED | Leukemia |
M.D. Anderson Cancer Center |
2001-03 | PHASE2 |
| NCT00866307 | COMPLETED | Acute Lymphoblastic Leukemia; Adult B Acute Lymphoblastic Leukemia; Childhood B Acute Lymphoblastic Leukemia |
Children's Oncology Group |
2009-02-23 | PHASE1 |
| NCT00632827 | TERMINATED | Peripheral T-Cell Lymphoma |
University of California, San Francisco |
2008-07-01 | PHASE2 |
| NCT01000285 | COMPLETED | Leukemia-Lymphoma, Adult T-Cell |
Washington University School of Medicine |
2010-09 | PHASE1; PHASE2 |
| NCT00458848 | COMPLETED | Leukemia |
Gruppo Italiano Malattie EMatologiche dell'Adulto |
2004-10 | PHASE2 |
| NCT01415765 | WITHDRAWN | Lymphoma, Diffuse Large-Cell B-cell; Diffuse, Large B-cell Lymphoma; Lymphoma, Diffuse Large-Cell; Large-Cell Lymphoma, Diffuse |
National Cancer Institute (NCI) |
2011-07-15 | PHASE1; PHASE2 |
| NCT01414855 | COMPLETED | Lymphoma, B-Cell |
Genentech, Inc. |
2011-08-31 | PHASE2 |
| NCT00103285 | COMPLETED | Acute Lymphoblastic Leukemia; Childhood B Acute Lymphoblastic Leukemia |
Children's Oncology Group |
2005-04-11 | PHASE3 |
| NCT00290667 | COMPLETED | Lymphoma |
German High-Grade Non-Hodgkin's Lymphoma Study Group |
2004-02 | PHASE2 |
| NCT00107380 | COMPLETED | Lymphoma |
SWOG Cancer Research Network |
2005-11 | PHASE2 |
| NCT01014767 | TERMINATED | Brain Cancer; Choroid Plexus Tumors |
Tufts Medical Center |
2009-11 | PHASE3 |
| NCT01004991 | COMPLETED | Diffuse Large B Cell Lymphoma |
Weill Medical College of Cornell University |
2010-01 | PHASE1; PHASE2 |
| NCT00671658 | COMPLETED | Leukemia; Acute Lymphoblastic Leukemia |
M.D. Anderson Cancer Center |
2002-11 | PHASE2 |
| NCT00541411 | UNKNOWN | Ewing's Sarcoma |
King Faisal Specialist Hospital & Research Center |
2003-06 | |
| NCT01005914 | TERMINATED | Leukemia |
OHSU Knight Cancer Institute |
2009-06 | PHASE2 |
| NCT00072384 | COMPLETED | Intraocular Retinoblastoma |
Children's Oncology Group |
2007-04-16 | PHASE3 |
| NCT00993044 | COMPLETED | Refractory Solid Tumors in Children |
Children's Hospital Los Angeles |
2009-09 | PHASE1 |
| NCT00882206 | TERMINATED | Leukemia; Lymphoma |
Masonic Cancer Center, University of Minnesota |
2009-04 | PHASE2 |
| NCT00911183 | COMPLETED | Lymphoma |
Institut Bergonié |
2008-12-02 | PHASE2 |
| NCT00184002 | COMPLETED | Non-Hodgkin's Lymphoma |
University of Southern California |
2003-01-10 | PHASE2 |
| NCT00555464 | TERMINATED | Hemangioma |
Medical College of Wisconsin |
2007-11 | PHASE2 |
| NCT00376961 | COMPLETED | Lymphoma |
SWOG Cancer Research Network |
2006-08 | PHASE2 |
| NCT00581776 | COMPLETED | Mantle Cell Lymphoma |
University of Wisconsin, Madison |
2005-05 | PHASE2 |
| NCT00853008 | COMPLETED | Acute Lymphoblastic Leukemia |
PETHEMA Foundation |
2003-01 | PHASE4 |
| NCT00262925 | TERMINATED | Recurrent Adult Acute Lymphoblastic Leukemia |
National Cancer Institute (NCI) |
2006-06 | PHASE2 |
| NCT00544219 | COMPLETED | Lymphoma |
Swiss Cancer Institute |
2007-09 | |
| NCT00666484 | COMPLETED | Lymphoma; Neurotoxicity |
University College, London |
2008-03 | PHASE2 |
| NCT01040871 | COMPLETED | Diffuse Large B-Cell Lymphoma |
Millennium Pharmaceuticals, Inc. |
2010-01 | PHASE2 |
| NCT00268853 | COMPLETED | Diffuse Large-Cell Lymphoma |
CTI BioPharma |
2005-11 | PHASE2 |
| NCT00877006 | COMPLETED | Non-Hodgkin's Lymphoma; Mantle Cell Lymphoma |
Teva Branded Pharmaceutical Products R&D, Inc. |
2009-04-30 | PHASE3 |
| NCT01181999 | UNKNOWN | Lymphoma, Large B-cell, Diffuse |
Chonnam National University Hospital |
2010-08 | PHASE2 |
| NCT01468740 | UNKNOWN | HIV-associated Hodgkin Lymphoma |
Harlachinger Krebshilfe e.V. |
2004-03 | PHASE2 |
| NCT00430118 | COMPLETED | Leukemia |
University Hospital Schleswig-Holstein |
2000-07 | PHASE3 |
| NCT00901069 | COMPLETED | Lymphoma; Hodgkin Disease; Lymphoma, Non-Hodgkin |
Shams Shakil |
2009-05 | PHASE1 |
| NCT00020566 | UNKNOWN | Sarcoma |
University of Leicester |
2001-02 | PHASE3 |
| NCT00184041 | COMPLETED | Acute Lymphoblastic Leukemia |
University of Southern California |
2004-07 | PHASE2 |
| NCT00002766 | COMPLETED | Leukemia; Lymphoma |
Memorial Sloan Kettering Cancer Center |
1996-03 | PHASE3 |
| NCT00006721 | COMPLETED | Lymphoma |
SWOG Cancer Research Network |
2001-03 | PHASE3 |
| NCT00133991 | COMPLETED | Leukemia; Lymphoma |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2005-07 | PHASE2 |
| NCT01009970 | UNKNOWN | Diffuse Large B-Cell Lymphoma |
Fondazione Italiana Linfomi - ETS |
2010-05 | PHASE2 |
| NCT00379457 | UNKNOWN | Sarcoma |
European Paediatric Soft Tissue Sarcoma Study Group |
2006-06 | PHASE3 |
| NCT00031590 | TERMINATED | Brain Tumors; Central Nervous System Tumors; Medulloblastoma |
Children's Hospital of Philadelphia |
2001-04 | PHASE2 |
| NCT00983944 | WITHDRAWN | Lymphoma |
Ohio State University Comprehensive Cancer Center |
2009-09 | PHASE2 |
| NCT00245089 | UNKNOWN | Sarcoma |
Japan Rhabdomyosarcoma Study Group |
2004-05 | PHASE2 |
| NCT00245141 | UNKNOWN | Sarcoma |
Japan Rhabdomyosarcoma Study Group |
2004-05 | PHASE2 |
| NCT00991133 | COMPLETED | Lymphoblastic Leukemia, Acute, Childhood |
Genzyme, a Sanofi Company |
2009-10 | PHASE1 |
| NCT00562965 | TERMINATED | Lymphoma, Follicular |
Pfizer |
2007-11 | PHASE3 |
| NCT01184885 | COMPLETED | Lymphoid Malignancies (New or Relapsed); Acute Lymphoblastic Leukemia; Burkitt Lymphoma; Lymphoblastic Lymphoma; Mantle Cell Lymphoma; Adult T-cell Leukemia/Lymphoma |
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University |
2010-07 | EARLY_PHASE1 |
| NCT00131027 | UNKNOWN | Lymphoblastic Leukemia, Acute |
Japan Adult Leukemia Study Group |
2002-09 | PHASE3 |
| NCT00088881 | TERMINATED | Contiguous Stage II Adult Diffuse Large Cell Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Nodal Marginal Zone B-cell Lymphoma; Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma; Splenic Marginal Zone Lymphoma; Stage I Adult Diffuse Large Cell Lymphoma; Testicular Lymphoma; Waldenström Macroglobulinemia |
National Cancer Institute (NCI) |
2004-12 | PHASE2 |
| NCT00440726 | COMPLETED | Acute Lymphoblastic Leukemia |
Therapeutic Advances in Childhood Leukemia Consortium |
2006-08-04 | PHASE1; PHASE2 |
| NCT00960063 | TERMINATED | Neoplasms; Solid Tumors; Bone Cancer; Kidney Tumor; Neuroblastoma |
Merck Sharp & Dohme LLC |
2009-11-11 | PHASE1 |
| NCT00392886 | UNKNOWN | Brain and Central Nervous System Tumors |
Children's Hospital Los Angeles |
2004-03 | PHASE3 |
| NCT01066429 | UNKNOWN | Diffuse Large B-Cell Lymphoma (DLBCL) |
Hospital Universitario Principe de Asturias |
2009-12 | PHASE2 |
| NCT01527422 | COMPLETED | Lymphoma; Non Hodgkin's Lymphoma |
Fernando Cabanillas |
2006-01 | PHASE1; PHASE2 |
| NCT01458730 | COMPLETED | Central Nervous System Lymphoma |
University of Aarhus |
2007-05 | PHASE2 |
| NCT00801580 | UNKNOWN | Lymphoid Leukemia |
University of Bologna |
2008-03 | PHASE2 |
| NCT00495079 | COMPLETED | Acute Lymphoblastic Leukemia (ALL) |
Spectrum Pharmaceuticals, Inc |
2007-05 | PHASE2 |
| NCT00503594 | UNKNOWN | Lymphoma |
Assistance Publique - Hôpitaux de Paris |
2007-07 | PHASE2 |
| NCT00928200 | TERMINATED | Relapsed Acute Lymphoblastic Leukemia; Allergy to PEG e.Coli Asparaginase; Allergy to Native e.Coli Asparaginase |
Therapeutic Advances in Childhood Leukemia Consortium |
2009-04-13 | PHASE1 |
| NCT00135499 | TERMINATED | Lymphoma, Large-Cell, Diffuse |
Lymphoma Study Association |
2001-10-16 | PHASE3 |
| NCT00077207 | COMPLETED | Brain Tumor; Central Nervous System Tumor |
Children's Oncology Group |
2004-07 | |
| NCT00274911 | UNKNOWN | Brain and Central Nervous System Tumors |
Children's Cancer and Leukaemia Group |
2004-02 | PHASE2 |
| NCT00186979 | COMPLETED | Solid Tumors |
St. Jude Children's Research Hospital |
2003-05 | PHASE1 |
| NCT00278278 | UNKNOWN | Brain and Central Nervous System Tumors |
German Society for Pediatric Oncology and Hematology GPOH gGmbH |
2003-09 | PHASE3 |
| NCT00392340 | UNKNOWN | Neuroblastoma |
Children's Cancer and Leukaemia Group |
2008-03 | PHASE2 |
| NCT00126191 | TERMINATED | Burkitt Lymphoma; Non-Hodgkins Lymphoma; Atypical Burkitt Lymphoma |
Dana-Farber Cancer Institute |
2005-07 | PHASE2 |
| NCT00071058 | COMPLETED | Adrenal Cortex Neoplasms |
National Cancer Institute (NCI) |
2003-10 | PHASE2 |
| NCT00057811 | COMPLETED | Childhood Burkitt Lymphoma; Childhood Diffuse Large Cell Lymphoma; Childhood Immunoblastic Large Cell Lymphoma; Stage I Childhood Large Cell Lymphoma; Stage I Childhood Small Noncleaved Cell Lymphoma; Stage II Childhood Large Cell Lymphoma; Stage II Childhood Small Noncleaved Cell Lymphoma; Stage III Childhood Large Cell Lymphoma; Stage III Childhood Small Noncleaved Cell Lymphoma; Stage IV Childhood Large Cell Lymphoma; Stage IV Childhood Small Noncleaved Cell Lymphoma; Untreated Childhood Acute Lymphoblastic Leukemia |
Children's Oncology Group |
2004-06 | PHASE2 |
| NCT00562068 | UNKNOWN | Lymphoma; Small Intestine Cancer |
Cancer Research UK |
2007-05 | PHASE1 |
| NCT00494780 | COMPLETED | Lymphoma, Follicular |
GlaxoSmithKline |
2007-06 | PHASE2 |
| NCT00313079 | COMPLETED | Leukemia, Lymphocytic; Leukemia; Acute Lymphocytic Leukemia |
Steven E. Coutre |
2006-05 | PHASE1 |
| NCT00718757 | COMPLETED | Non-Hodgkins Lymphoma; Hodgkin's Disease; Acute Lymphoblastic Leukemia |
St. Jude Children's Research Hospital |
2005-01 | PHASE1 |
| NCT00618501 | COMPLETED | Leukemia |
Asan Medical Center |
2005-10 | PHASE2 |
| NCT00025103 | UNKNOWN | Kidney Cancer |
Children's Cancer and Leukaemia Group |
2001-05 | PHASE2 |
| NCT00136435 | COMPLETED | Acute Lymphoblastic Leukemia |
Dana-Farber Cancer Institute |
2002-06 | PHASE2 |
| NCT00384111 | TERMINATED | Follicular Lymphoma; Lymphoma, Follicular |
Spectrum Pharmaceuticals, Inc |
2006-10 | PHASE3 |
| NCT00301821 | COMPLETED | Lymphoma |
Alliance for Clinical Trials in Oncology |
2006-01 | PHASE2 |
| NCT00176462 | COMPLETED | Acute Lymphocytic Leukemia |
Rutgers, The State University of New Jersey |
2001-02 | PHASE2 |
| NCT00136084 | COMPLETED | Leukemia, Myelocytic, Acute |
St. Jude Children's Research Hospital |
2002-08 | PHASE3 |
| NCT00003728 | UNKNOWN | Leukemia; Lymphoma |
European Organisation for Research and Treatment of Cancer - EORTC |
1998-12 | PHASE3 |
| NCT00313053 | TERMINATED | Leukemia, Lymphocytic, Acute; Leukemia; Acute Lymphoid Leukemia (ALL) |
Clare Twist |
2004-09 | PHASE1 |
| NCT00072280 | TERMINATED | Sarcoma |
Children's Oncology Group |
2004-11 | PHASE2 |
| NCT00774202 | COMPLETED | Immune Thrombocytopenic Purpura |
Weill Medical College of Cornell University |
2003-11 | PHASE2; PHASE3 |
| NCT00061945 | COMPLETED | Acute Undifferentiated Leukemia; B-cell Adult Acute Lymphoblastic Leukemia; B-cell Childhood Acute Lymphoblastic Leukemia; L1 Adult Acute Lymphoblastic Leukemia; L1 Childhood Acute Lymphoblastic Leukemia; L2 Adult Acute Lymphoblastic Leukemia; L2 Childhood Acute Lymphoblastic Leukemia; Philadelphia Chromosome Negative Adult Precursor Acute Lymphoblastic Leukemia; Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia; Philadelphia Chromosome Positive Childhood Precursor Acute Lymphoblastic Leukemia; T-cell Adult Acute Lymphoblastic Leukemia; T-cell Childhood Acute Lymphoblastic Leukemia; Untreated Adult Acute Lymphoblastic Leukemia; Untreated Childhood Acute Lymphoblastic Leukemia |
National Cancer Institute (NCI) |
2003-06 | PHASE1; PHASE2 |
| NCT00003141 | COMPLETED | Brain Tumors; Central Nervous System Tumors; Neuroblastoma; Sarcoma |
Children's Oncology Group |
1998-03 | PHASE1 |
| NCT00337987 | COMPLETED | Peripheral T-Cell Lymphoma |
Yale University |
2005-11 | PHASE2 |
| NCT00058305 | COMPLETED | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Nodal Marginal Zone B-cell Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Small Lymphocytic Lymphoma; Splenic Marginal Zone Lymphoma |
National Cancer Institute (NCI) |
2003-03 | PHASE2 |
| NCT00005945 | COMPLETED | Leukemia |
Children's Oncology Group |
2000-06 | PHASE3 |
| NCT00041132 | COMPLETED | Lymphoma |
SWOG Cancer Research Network |
2002-09 | PHASE2 |
| NCT00763763 | COMPLETED | Leukemia, Lymphocytic, Acute; Philadelphia Chromosome; Blast Crisis; Leukemia, Myeloid, Chronic |
Assistance Publique - Hôpitaux de Paris |
2004-12 | PHASE2 |
| NCT00025363 | COMPLETED | Alveolar Childhood Rhabdomyosarcoma; Embryonal Childhood Rhabdomyosarcoma; Embryonal-botryoid Childhood Rhabdomyosarcoma; Previously Treated Childhood Rhabdomyosarcoma; Recurrent Childhood Rhabdomyosarcoma |
National Cancer Institute (NCI) |
2001-11 | PHASE2 |
| NCT00003573 | COMPLETED | Brain Tumors; Central Nervous System Tumors |
Children's Oncology Group |
1998-11 | PHASE2 |
| NCT00004188 | COMPLETED | Neuroblastoma |
Children's Oncology Group |
2001-02 | PHASE3 |
| NCT00003203 | COMPLETED | Brain Tumors; Central Nervous System Tumors; Neuroblastoma |
Children's Oncology Group |
1998-03 | PHASE2 |
| NCT00145041 | COMPLETED | Malignant Melanoma |
Acrotech Biopharma Inc. |
2005-02 | PHASE1 |
| NCT00005585 | COMPLETED | Leukemia |
Children's Oncology Group |
2000-04 | PHASE3 |
| NCT00003311 | COMPLETED | Lymphoma |
M.D. Anderson Cancer Center |
1998-05-20 | PHASE2 |
| NCT00002565 | COMPLETED | Lymphoma |
M.D. Anderson Cancer Center |
1994-05-25 | PHASE3 |
| NCT00002463 | COMPLETED | Brain and Central Nervous System Tumors |
M.D. Anderson Cancer Center |
1989-02 | PHASE2 |
| NCT00053768 | COMPLETED | Lymphoma |
German High-Grade Non-Hodgkin's Lymphoma Study Group |
2002-04 | PHASE3 |
| NCT00020943 | COMPLETED | Lymphoma |
Alliance for Clinical Trials in Oncology |
2001-06 | PHASE2 |
| NCT00041327 | COMPLETED | Lymphoma |
AIDS Malignancy Consortium |
2002-10 | PHASE2 |
| NCT00002676 | COMPLETED | Lymphoma |
Alliance for Clinical Trials in Oncology |
1995-07 | PHASE2 |
| NCT00006734 | COMPLETED | Sarcoma |
Children's Oncology Group |
2001-05 | PHASE3 |
| NCT00004231 | COMPLETED | Lymphoma |
Northwestern University |
1999-10 | PHASE2 |
| NCT00144963 | COMPLETED | Acute Lymphoblastic Leukemia |
Acrotech Biopharma Inc. |
2002-07 | PHASE1; PHASE2 |
| NCT00054158 | COMPLETED | Multiple Myeloma and Plasma Cell Neoplasm |
Roswell Park Cancer Institute |
2004-08 | PHASE2 |
| NCT00309881 | COMPLETED | Chronic Lymphocytic Leukemia |
German CLL Study Group |
2003-04 | PHASE2 |
| NCT01225874 | COMPLETED | Leukemia |
Children's Oncology Group |
1999-12 | |
| NCT00049569 | COMPLETED | L1 Childhood Acute Lymphoblastic Leukemia; L2 Childhood Acute Lymphoblastic Leukemia; Non-T, Non-B Childhood Acute Lymphoblastic Leukemia; Recurrent Childhood Acute Lymphoblastic Leukemia; T-cell Childhood Acute Lymphoblastic Leukemia |
National Cancer Institute (NCI) |
2003-01 | |
| NCT00005964 | COMPLETED | Lymphoma |
Alliance for Clinical Trials in Oncology |
2000-05 | PHASE2 |
| NCT01148446 | COMPLETED | Elderly Patients (>65 Years); Diffuse Large B Cell Lymphoma (DLBCL) |
Fondazione Italiana Linfomi - ETS |
2003-01 | PHASE3 |
| NCT00285389 | COMPLETED | Mantle Cell Lymphoma |
French Innovative Leukemia Organisation |
2002-02 | PHASE2 |
| NCT00284271 | COMPLETED | Hodgkin´s Lymphoma |
University of Cologne |
2004-01 | PHASE2 |
| NCT00017368 | COMPLETED | Neuroblastoma |
Children's Oncology Group |
2001-04 | PHASE2 |
| NCT00005596 | COMPLETED | Leukemia |
Children's Oncology Group |
2000-04 | PHASE3 |
| NCT00002466 | COMPLETED | Kidney Cancer; Sarcoma |
Memorial Sloan Kettering Cancer Center |
1990-05 | PHASE2 |
| NCT00002569 | COMPLETED | Brain and Central Nervous System Tumors |
Radiation Therapy Oncology Group |
1994-07 | PHASE3 |
| NCT00039351 | COMPLETED | Lymphoma |
European Organisation for Research and Treatment of Cancer - EORTC |
2002-03 | PHASE2 |
| NCT00003955 | COMPLETED | Sarcoma |
Children's Oncology Group |
1999-09 | PHASE2 |
| NCT00006095 | COMPLETED | Unspecified Childhood Solid Tumor, Protocol Specific |
Children's Oncology Group |
2000-07 | PHASE1 |
| NCT00032019 | COMPLETED | Lymphoma |
Alliance for Clinical Trials in Oncology |
2002-02 | PHASE2 |
| NCT00002827 | COMPLETED | Cardiac Toxicity; Lymphoma |
Children's Oncology Group |
1996-10 | PHASE3 |
| NCT00038207 | COMPLETED | Soft Tissue Sarcoma; Lymphoma; Leukemia; Wilms' Tumor; Osteosarcoma |
M.D. Anderson Cancer Center |
2000-06 | PHASE2 |
| NCT00002704 | COMPLETED | Leukemia |
National Cancer Institute (NCI) |
1996-01 | PHASE2 |
| NCT00187122 | COMPLETED | Lymphoblastic Lymphoma |
St. Jude Children's Research Hospital |
1993-03 | |
| NCT00004179 | COMPLETED | Lymphoma |
European Organisation for Research and Treatment of Cancer - EORTC |
1999-05 | PHASE3 |
| NCT00002494 | COMPLETED | Leukemia; Lymphoma |
Alliance for Clinical Trials in Oncology |
1992-05 | PHASE2 |
| NCT00003309 | COMPLETED | Brain and Central Nervous System Tumors |
Eastern Cooperative Oncology Group |
1999-05-04 | PHASE2 |
| NCT00002700 | COMPLETED | Leukemia; Lymphoma |
European Organisation for Research and Treatment of Cancer - EORTC |
1995-08 | PHASE3 |
| NCT00003700 | COMPLETED | Leukemia |
Alliance for Clinical Trials in Oncology |
1999-01 | PHASE2 |
| NCT00199056 | COMPLETED | Adult Acute Lymphocytic Leukemia |
Goethe University |
1999-10 | PHASE4 |
| NCT00002657 | COMPLETED | Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm |
SWOG Cancer Research Network |
1995-05 | PHASE2 |
| NCT00004010 | COMPLETED | Lymphoma |
Children's Oncology Group |
1999-10 | PHASE2 |
| NCT00002757 | COMPLETED | Leukemia; Lymphoma |
Children's Oncology Group |
2001-06 | PHASE3 |
| NCT00002548 | COMPLETED | Multiple Myeloma |
SWOG Cancer Research Network |
1994-01 | PHASE3 |
| NCT00022555 | COMPLETED | AIDS-related Diffuse Large Cell Lymphoma; AIDS-related Diffuse Mixed Cell Lymphoma; AIDS-related Peripheral/Systemic Lymphoma; AIDS-related Small Noncleaved Cell Lymphoma |
National Cancer Institute (NCI) |
2001-11 | PHASE1 |
| NCT00199095 | COMPLETED | Adult Acute Lymphocytic Leukemia |
Goethe University |
1997-02 | PHASE4 |
| NCT00002878 | COMPLETED | Multiple Myeloma and Plasma Cell Neoplasm |
Eastern Cooperative Oncology Group |
1997-06-30 | PHASE3 |
| NCT00072007 | COMPLETED | Leukemia |
Swiss Cancer Institute |
2002-06 | PHASE2 |
| NCT00002806 | COMPLETED | Brain and Central Nervous System Tumors |
Alliance for Clinical Trials in Oncology |
1996-07 | PHASE2 |
| NCT00002471 | COMPLETED | Leukemia; Lymphoma |
Memorial Sloan Kettering Cancer Center |
1990-02 | PHASE2 |
| NCT00003671 | COMPLETED | Leukemia |
Children's Oncology Group |
1998-12 | PHASE2 |
| NCT00002816 | COMPLETED | Leukemia |
Children's Oncology Group |
1996-12 | PHASE3 |
| NCT00187005 | TERMINATED | Acute Lymphoblastic Leukemia |
St. Jude Children's Research Hospital |
1998-07 | PHASE3 |
| NCT00002610 | COMPLETED | Kidney Cancer |
Children's Oncology Group |
1996-01 | PHASE3 |
| NCT00002611 | COMPLETED | Kidney Cancer |
Children's Oncology Group |
1995-07 | PHASE3 |
| NCT00002840 | COMPLETED | Brain and Central Nervous System Tumors |
European Organisation for Research and Treatment of Cancer - EORTC |
1996-08 | PHASE3 |
| NCT00002665 | COMPLETED | Leukemia; Neutropenia; Thrombocytopenia |
SWOG Cancer Research Network |
1995-07 | PHASE2 |
| NCT00187070 | COMPLETED | Lymphoma, Large Cell; Lymphoma, Non-Hodgkin |
St. Jude Children's Research Hospital |
1997-12 | |
| NCT00003166 | COMPLETED | Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Multiple Myeloma; Stage III Multiple Myeloma |
National Cancer Institute (NCI) |
1998-05 | PHASE1 |
| NCT00002794 | COMPLETED | Retinoblastoma |
St. Jude Children's Research Hospital |
1996-02 | PHASE2 |
| NCT00003625 | COMPLETED | Brain Tumors; Central Nervous System Tumors |
Children's Oncology Group |
1998-12 | PHASE1 |
| NCT00003847 | TERMINATED | Lung Cancer |
Vertex Pharmaceuticals Incorporated |
1998-12 | PHASE2 |
| NCT00004162 | COMPLETED | Lymphoma |
University of Alabama at Birmingham |
1997-06 | PHASE1 |
| NCT00002618 | COMPLETED | Lymphoma |
Children's Oncology Group |
1994-12 | PHASE3 |
| NCT00002691 | COMPLETED | Lymphoma |
Memorial Sloan Kettering Cancer Center |
1995-08 | PHASE2 |
| NCT00002462 | ACTIVE_NOT_RECRUITING | Lymphoma |
European Organisation for Research and Treatment of Cancer - EORTC |
1989-09 | PHASE3 |
| NCT00006669 | WITHDRAWN | Lymphoma |
Medstar Health Research Institute |
1999-09 | PHASE2 |
| NCT00004039 | WITHDRAWN | Lymphoma |
Hoag Memorial Hospital Presbyterian |
1998-06 | PHASE2 |
| NCT00199069 | COMPLETED | Adult Acute Lymphocytic Leukemia |
Goethe University |
1993-04 | PHASE4 |
| NCT00379041 | ACTIVE_NOT_RECRUITING | Lymphoma |
European Organisation for Research and Treatment of Cancer - EORTC |
1993-09-01 | PHASE3 |
| NCT00028886 | UNKNOWN | Multiple Myeloma and Plasma Cell Neoplasm |
Commissie Voor Klinisch Toegepast Onderzoek |
2001-03 | PHASE3 |
| NCT00000658 | COMPLETED | Lymphoma, Non-Hodgkin; HIV Infections |
National Institute of Allergy and Infectious Diseases (NIAID) |
PHASE3 | |
| NCT00556127 | COMPLETED | Diffuse Large B-Cell Lymphoma; POOR PROGNOSIS |
Gruppo Italiano Multiregionale per lo studio dei Linfomi e delle Leucemie |
2002-06 | PHASE2 |
| NCT00001339 | COMPLETED | Adrenal Cortical Carcinoma |
National Cancer Institute (NCI) |
1993-08 | PHASE2 |
| NCT00003421 | COMPLETED | Lymphoma |
Medical Research Council |
1998-06 | PHASE3 |
| NCT00025649 | COMPLETED | Neuroblastoma |
European Infant Neuroblastoma Study Group - 1999 |
1999-07 | PHASE2 |
| NCT00000954 | COMPLETED | Sarcoma, Kaposi; HIV Infections |
National Institute of Allergy and Infectious Diseases (NIAID) |
PHASE1 | |
| NCT00734773 | WITHDRAWN | Brain and Central Nervous System Tumors; Lymphoma; Neurotoxicity |
Northwestern University |
2008-11 | EARLY_PHASE1 |
| NCT00025428 | COMPLETED | Neuroblastoma |
Societe Internationale d'Oncologie Pediatrique |
2000-12 | PHASE3 |
| NCT00161564 | WITHDRAWN | Idiopathic Thrombocytopenic Purpura (ITP) |
Weill Medical College of Cornell University |
2004-02 | PHASE2 |
| NCT00025441 | COMPLETED | Ovarian Cancer; Sarcoma; Small Intestine Cancer |
Societe Internationale d'Oncologie Pediatrique |
1998-11 | PHASE2 |
| NCT00002898 | COMPLETED | Childhood Malignant Fibrous Histiocytoma of Bone; Sarcoma |
Societe Internationale d'Oncologie Pediatrique |
1995-01 | PHASE3 |
| NCT00025064 | UNKNOWN | Lymphoma |
Children's Cancer and Leukaemia Group |
2000-01 | PHASE2 |
| NCT00003437 | UNKNOWN | Leukemia |
Medical Research Council |
1997-01 | PHASE3 |
| NCT00006232 | COMPLETED | Multiple Myeloma and Plasma Cell Neoplasm |
West of Scotland Lymphoma Group |
1996-10 | PHASE3 |
| NCT00005959 | UNKNOWN | Lymphoma |
Amgen |
1999-12 | PHASE2 |
| NCT00344422 | COMPLETED | Multiple Myeloma; Myeloma; M-Protein; Myeloma Proteins |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
2000-10 | PHASE3 |
| NCT00002499 | UNKNOWN | Leukemia |
Grupo Argentino de Tratamiento de la Leucemia Aguda |
1990-01 | PHASE2; PHASE3 |
| NCT00004224 | COMPLETED | Brain and Central Nervous System Tumors |
Societe Internationale d'Oncologie Pediatrique |
1999-01 | PHASE2 |
| NCT00003262 | UNKNOWN | Lymphoma |
Centro di Riferimento Oncologico - Aviano |
1997-05 | PHASE2 |
| NCT00002531 | UNKNOWN | Leukemia |
Johann Wolfgang Goethe University Hospital |
1993-01 | PHASE2 |
| NCT00491946 | UNKNOWN | Cancer |
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) |
2004-06 | PHASE4 |
| NCT00004218 | COMPLETED | Leukemia |
Leukemia Research Fund |
1999-10 | PHASE3 |
| NCT00070447 | COMPLETED | Lymphoma |
National Cancer Institute (NCI) |
2003-11 | PHASE2 |
| NCT00041210 | UNKNOWN | Lymphoma |
Mount Vernon Cancer Centre at Mount Vernon Hospital |
2001-10 | PHASE3 |
| NCT00028717 | UNKNOWN | Lymphoma |
Commissie Voor Klinisch Toegepast Onderzoek |
2001-02 | PHASE3 |
| NCT00001209 | COMPLETED | Neuroectodermal Tumor, Primitive; Neuroepithelioma; Osteosarcoma; Sarcoma; Sarcoma, Ewing's |
National Cancer Institute (NCI) |
1986-10 | PHASE1 |
| NCT00417053 | UNKNOWN | Neuroblastoma |
Children's Cancer and Leukaemia Group |
PHASE3 | |
| NCT00003273 | WITHDRAWN | Brain and Central Nervous System Tumors; Neuroblastoma; Retinoblastoma; Sarcoma |
NYU Langone Health |
1997-11 | PHASE2 |
| NCT00276731 | UNKNOWN | Neuroblastoma |
Children's Cancer and Leukaemia Group |
1995-03 | PHASE3 |
| NCT00022945 | COMPLETED | Mantle Cell Lymphoma |
Corixa Corporation |
PHASE2 | |
| NCT00343369 | UNKNOWN | Leukemia |
Universitätsklinikum Hamburg-Eppendorf |
2003-01 | |
| NCT00187161 | COMPLETED | Non-Hodgkin Lymphoma; Acute Lymphoblastic Leukemia, Mature B-Cell |
St. Jude Children's Research Hospital |
1994-11 | PHASE2 |
| NCT00018954 | COMPLETED | Leukemia; Lymphoma |
National Institutes of Health Clinical Center (CC) |
1992-10 | PHASE2 |
| NCT00281905 | UNKNOWN | Brain and Central Nervous System Tumors; Neuroblastoma |
Children's Cancer and Leukaemia Group |
1992-06 | PHASE2 |
| NCT00080925 | COMPLETED | Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms |
National Institutes of Health Clinical Center (CC) |
2004-02 | PHASE1 |
| NCT00030719 | UNKNOWN | Neuroblastoma |
University of Leicester |
2001-12 | PHASE3 |
| NCT00003493 | COMPLETED | Multiple Myeloma and Plasma Cell Neoplasm |
The Cleveland Clinic |
1998-11 | PHASE2 |
| NCT00025623 | COMPLETED | Neuroblastoma |
European Infant Neuroblastoma Study Group - 1999 |
1999-07 | PHASE2 |
| NCT00012207 | COMPLETED | Leukemia; Lymphoma |
Fred Hutchinson Cancer Center |
2000-09 | PHASE1 |
| NCT00669812 | UNKNOWN | Lymphoma; Small Intestine Cancer |
Cancer Research UK |
2008-02 | PHASE2 |
| NCT00002987 | UNKNOWN | Lymphoma |
Medical Research Council |
1997-01 | PHASE3 |
| NCT00365755 | COMPLETED | Neuroblastoma |
Children's Cancer and Leukaemia Group |
PHASE3 | |
| NCT00416377 | UNKNOWN | Lymphoma |
Children's Cancer and Leukaemia Group |
||
| NCT00003578 | UNKNOWN | Lymphoma |
Lymphoma Trials Office |
1993-01 | PHASE3 |
| NCT00025610 | COMPLETED | Neuroblastoma |
European Infant Neuroblastoma Study Group - 1999 |
1999-07 | PHASE2 |
| NCT00053872 | UNKNOWN | Brain and Central Nervous System Tumors |
University of Leicester |
2003-02 | PHASE3 |
| NCT00427570 | COMPLETED | Colorectal Cancer |
NSABP Foundation Inc |
1977-09 | PHASE3 |
| NCT00201318 | COMPLETED | Non-Hodgkin's Lymphoma |
National Health Research Institutes, Taiwan |
2001-09 | PHASE2 |
| NCT00001689 | COMPLETED | Acute Lymphocytic Leukemia; Leukemia |
National Cancer Institute (NCI) |
1998-01 | PHASE1 |
(data from https://clinicaltrials.gov, updated on 2026-06-11)
Check the
Vincristine (Leurocristine) Sulfate
product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.
Mechanism and Biochemical Profile
Appendix RUO and cGMP Quality Standards
| Quality Dimension | RUO (Research Use Only) | cGMP (Current Good Manufacturing Practice) |
|---|---|---|
| Clinical Applicability | Prohibited in human clinical trials or medical diagnostics. | Mandatory for human clinical trials (Phase I–III) and therapies. |
| Regulatory Status | Non-regulated grade; exempt from drug manufacturing laws. | Legally enforced by health authorities (e.g., FDA, EMA, NMPA). |
| Facility Environment | Unclassified analytical or research laboratories. | Validated Cleanrooms (ISO Class 5–8) with continuous monitoring. |
| Quality Control | Basic purity and activity testing. | Rigorous safety release testing (Sterility, Endotoxin, Mycoplasma). |
| Process Validation | Basic equipment calibration; no process validation required. | Full qualification (IQ/OQ/PQ) and complete batch records. |
| Quality Assurance | Vendor self-declared without required formal QMS. | Mandatory QA/QC unit, Change Control, CAPA, and vendor audits. |
| Regulatory Impact | High risk of IND rejection if used as a critical raw material. | Required for IND/NDA filings, supported by Drug Master Files (DMF). |
Footnotes
Regulatory Note: Governed by FDA (21 CFR Parts 210/211/312), EMA (EudraLex Vol 4), ICH Guidelines (E6/Q7/Q9/Q10), and compendial standards (USP <71>/<85>/<1043>).
- Vincristine (Leurocristine) Sulfate Mechanism of Action: NLRP3 Inflammasome Inhibition in Macrophage Research
- Vincristine (Leurocristine) Sulfate Working Concentration | Cell Culture | Treatment
- Vincristine (Leurocristine) Sulfate Solubility in DMSO
- Vincristine (Leurocristine) Sulfate Stock Solution
- Vincristine (Leurocristine) Sulfate Storage
- Vincristine (Leurocristine) Sulfate Stability
- Vincristine (Leurocristine) Sulfate Combination Database
- Vincristine (Leurocristine) Sulfate Molecular Weight
- Vincristine (Leurocristine) Sulfate SMILES
- Vincristine (Leurocristine) Sulfate CAS Number
- Vincristine (Leurocristine) Sulfate Chemical Structure (2D and 3D)
- Vincristine (Leurocristine) Sulfate IC50 for Cell-based and Cell-free Assays
- Vincristine (Leurocristine) Sulfate Sigma (V8879)? Try a better option.
- Vincristine (Leurocristine) Sulfate MedChemExpress (HY-N0488)? Try a better option.
- Vincristine (Leurocristine) Sulfate Cayman (11764)? Try a better option.
- Vincristine (Leurocristine) Sulfate APExBIO (A1765)? Try a better option.
- Vincristine (Leurocristine) Sulfate SDS｜MSDS
Note: Technical data last updated: Sep 1, 2026.